Issue 368

Welcome back to E&O: a subscribers-only weekly-ish newsletter focused on the business, regulation, and effectiveness of health tech.

AI Refill

• • •

In this issue of E&O

  • E&O's report on Doctronic's direct-to-consumer AI prescription refill experiment in Utah drummed up a lot interest (and bunch of new readers -- welcome!). So, this week I compiled a a few other details that didn't make it into the original article,

Sign-up for the newsletter for access.

It's a good one, too.

This article is for Exits & Outcomes subscribers only. Subscribe now to get the weekly newsletter. Enter your email below to subscribe today!

×

Newsletters

All Newsletters
Six years of Oura’s financials: Revenue, profits, marketing spend and more
5.22.26
4 min. Read
ACCESS Model’s first dropout? Plus: A few new participants
5.08.26
6 min. Read
Emails show how Doctronic’s AI pilot blindsided Utah’s Medical Board
4.10.26
13 min. Read
Quiet funding rounds. Plus: Digital health-related clinical trial round-ups
3.20.26
5 min. Read
Details: Vida Health’s brief GLP-1 rollout in Mass. Plus: CMS says Freespira not DME
3.13.26
7 min. Read
ACCESS Model’s shockingly low payments. DMHT Rx count.
2.13.26
7 min. Read
HLTH acquisition price. Estimating Pomelo Care pricing, revenue, and more
1.09.26
7 min. Read
CMS to pay for ADHD DTx. More PFS notes. Two FDA De Novos.
11.07.25
6 min. Read
Pricing for Sword Health, Hinge Health, Joint Academy in the UK.
10.31.25
7 min. Read
Spring, Slingshot AI, Click and others write FDA about GenAI. Big Health board departs.
10.24.25
7 min. Read

Databases

All Databases
Results of digital health requests for CPT Codes (2012-2025)
11.25.25
< 1 min. Read
Pricing for 140+ Digital Health Programs
12.06.24
< 1 min. Read

Research Reports

All Research Reports
Approximating Omada Health’s S-1 Before Its 2025 IPO
11.22.24
21 min. Read
The Spring Health Report
8.18.23
20 min. Read